Tevapharm India Private Limited

Tevapharm India Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U33111MH2000FTC326700 Incorporated 01 December 2000 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company pharma
Revenue · FY 2025
₹459.24 Cr
▼ 9% YoY
Net profit · FY 2025
₹66.56 Cr
Net margin 14.5%
EBITDA · FY 2025
₹103.72 Cr
EBITDA margin 22.6%
Authorised capital
₹700 Cr
Registered with MCA
Paid-up capital
₹220.19 Cr
Issued & subscribed
Company age
26 yrs
Est. 2000
Employees · EPFO
954
Provident fund records
Directors on board
4
As per MCA filings

About Tevapharm India Private Limited

Data last updated:

Tevapharm India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ratiopharm Gmbh. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33111MH2000FTC326700. Its GSTIN is 27AABCR7561F1ZA (Maharashtra). The company holds 5 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹700 Cr and a paid-up capital of ₹220.19 Cr. It was formerly known as Ratiopharm India Private Limited. It is led by directors including Nishank Bhargava and Pooja Singh.

Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹459.24 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹66.56 Cr (net margin 14.5%) and EBITDA of ₹103.72 Cr (EBITDA margin 22.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 6% over five years.

The company has about 954 employees on its provident fund (EPFO) records.

Court records list 4 cases involving the company, including 4 filed against it. The company has 10 deals on record (5 funding rounds, 4 secondary share transfers, 1 acquisition), with disclosed funding of ₹399.66 Cr; the latest was in September 2023. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 415 overdue payments to 86 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.com.

Company details

CIN U33111MH2000FTC326700
Registration Number 326700
Incorporation Date 01 December 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Ratiopharm Gmbh
Compliance Status Active Compliant

CIN history

Tevapharm India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33111MH2000FTC326700, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33111MH2000FTC326700Current
U33111DL2000FTC268478Previous
U33111MH2000FTC129835Previous

Contact details

Tevapharm India Private Limited's registered office is in Mumbai, Maharashtra. Its website is tevapharm.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Tevapharm India Private Limited, buy the company report.

Comprehensive company report
Tevapharm India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Tevapharm India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Tevapharm India Private Limited, buy the company report.

Financials of Tevapharm India Private Limited

FY 2025 filings available

Tevapharm India Private Limited reported revenue of ₹459.24 Cr (down 9% YoY) for FY 2025.

Revenue · FY 2025
₹459.24 Cr ▼ 9%
Net profit · FY 2025
₹66.56 Cr margin 14.5%
EBITDA · FY 2025
₹103.72 Cr margin 22.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 24%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 18%

Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹103.72 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹66.56 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.6%
Net Profit Margin14.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tevapharm India Private Limited, buy the company report.

Board of directors of Tevapharm India Private Limited

Tevapharm India has 4 current directors and 30 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nishank BhargavaDirector24 Feb 20224 Years 8 MonthsCurrent
Pooja SinghDirector03 Jun 20251 Years 5 MonthsCurrent
Vinod Narayan ShettyDirector24 Aug 20215 Years 2 MonthsCurrent
Gubbi Channappa RoopaDirector27 Jun 20242 Years 4 MonthsCurrent

Auditor

Tevapharm India Private Limited is audited by SRBC & CO LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SRBC & CO LLPFY 2023324982E/E300003

Shareholding

The shareholding of Tevapharm India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tevapharm India Private Limited, buy the company report.

Deals & funding

Tevapharm India Private Limited has 10 deals on record (5 funding rounds, 4 secondary share transfers, 1 acquisition), with disclosed funding of ₹399.66 Cr; the latest was in September 2023.

Total deals
10
Funding rounds
5
Secondary share transfers
4
Acquisition
1
Disclosed funding
₹399.66 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Sep 2023Secondary share transferUndisclosedSeller: Teva Pharmaceutical Investments Singapore Pte Limited
Oct 2022AcquisitionUndisclosedBuyer: Marksans Pharma Limited
Seller: Tevapharm India Private Limited
Apr 2022Secondary share transferUndisclosedSeller: Teva Pharmaceutical Investments Singapore Pte Limited
Jul 2020Secondary share transferUndisclosedSeller: Teva Pharmaceutical Investments Singapore Pte Limited
Mar 2019Secondary share transferUndisclosedSeller: Teva Pharmaceutical Investments Singapore Pte Limited

To see the full deal history of Tevapharm India Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Tevapharm India Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 415 overdue payments to 86 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 86)

SupplierAmount dueDue sinceReported on
an individual supplier
Perks Links and Services Private Limited
an individual supplier
an individual supplier
Zalani Stationery Mart

To see the full MSME payment records of Tevapharm India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Tevapharm India Private Limited has a workforce of 954 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
954
Active EPFO establishments
2
Employee growth
-7.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27954
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Tevapharm India Private Limited, buy the company report.

GST

Tevapharm India has 5 GST registrations: 4 active and 1 cancelled or inactive.

Total GSTINs
5
Active
4
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AABCR7561F1ZAMaharashtraActive01 Jul 2017
27AABCR7561F2Z9MaharashtraActive11 Mar 2025
30AABCR7561F1ZNGoaActive01 Jul 2017
29AABCR7561F1Z6KarnatakaActive25 Nov 2019

To see the full GST registrations and return filing status of Tevapharm India Private Limited, buy the company report.

Recent activity

Tevapharm India Private Limited has 32 board changes on record since 2008: 4 appointments and 28 cessations. The latest: Pooja Singh ceased to be Additional Director on 31 Aug 2025.

AGM
Tevapharm India Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records.
Ceased
Pooja Singh ceased to be Additional Director.
Appointed
Pooja Singh was appointed as Director.
Filing
Tevapharm India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Gubbi Channappa Roopa ceased to be Additional Director.
Appointed
Gubbi Channappa Roopa was appointed as Director.
Ceased
Anuradha Ganesh Naik ceased to be Company Secretary.
Ceased
Nishank Bhargava ceased to be Additional Director.
Ceased
Vinod Narayan Shetty ceased to be Additional Director.
Appointed
Nishank Bhargava was appointed as Director.
Ceased
Pramod Ramchandra Ghorpade ceased to be Director.
Appointed
Vinod Narayan Shetty was appointed as Director.

23 earlier events are in the company report.

Frequently asked questions

Tevapharm India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2000 (26+ years old) and is registered under CIN U33111MH2000FTC326700.

Tevapharm India has 4 current directors:

The latest financial statements of Tevapharm India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Tevapharm India is 27AABCR7561F1ZA, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AABCR7561F2Z9 (Maharashtra), 30AABCR7561F1ZN (Goa), 29AABCR7561F1Z6 (Karnataka).

The CIN (Corporate Identification Number) of Tevapharm India is U33111MH2000FTC326700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tevapharm India has 4 court cases on record: 4 filed against it. Most are in the high courts.

Tevapharm India was incorporated on 01 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.

Tevapharm India has 10 deals on record (5 funding rounds, 4 secondary share transfers, 1 acquisition), with disclosed funding of ₹399.66 Cr; the latest was in September 2023.

Pooja Singh ceased to be Additional Director on 31 Aug 2025. Pooja Singh was appointed as Director on 03 Jun 2025. Gubbi Channappa Roopa ceased to be Additional Director on 01 Sep 2024. Tevapharm India has 32 board changes on record in total.

Tevapharm India has 13 MSME Form 1 returns on record between 2019 and 2024, listing 415 overdue payments to 86 micro and small suppliers. The latest return was filed on 29 Apr 2024.

Tevapharm India can be reached through the website tevapharm.com. Its registered office is in Mumbai, Maharashtra, India.